Search Results

There are 10093 results for: content related to: Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study

  1. You have free access to this content
    Bile salt–phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent

    Hepatology

    Volume 50, Issue 1, July 2009, Pages: 143–154, Walee Chamulitrat, Jürgen Burhenne, Tobias Rehlen, Anita Pathil and Wolfgang Stremmel

    Version of Record online : 16 MAR 2009, DOI: 10.1002/hep.22955

  2. You have free access to this content
    Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 8, August 1999, Pages: 979–995, Trauner and Graziadei

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00596.x

  3. You have free access to this content
    Poster Session 1: Pathogenesis and Mechanisms; PBC/PSC and Other Cholestatic Disease

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 498A–530A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28214

  4. You have free access to this content
    Ursodeoxycholic acid attenuates colonic epithelial secretory function

    The Journal of Physiology

    Volume 591, Issue 9, May 2013, Pages: 2307–2318, Orlaith B. Kelly, Magdalena S. Mroz, Joseph B. J. Ward, Carolina Colliva, Michael Scharl, Roberto Pellicciari, John F. Gilmer, Padraic G. Fallon, Alan F. Hofmann, Aldo Roda, Frank E. Murray and Stephen J. Keely

    Version of Record online : 10 APR 2013, DOI: 10.1113/jphysiol.2013.252544

  5. You have free access to this content
    Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid

    Hepatology

    Volume 57, Issue 5, May 2013, Pages: 1931–1941, Akira Honda, Tadashi Ikegami, Makoto Nakamuta, Teruo Miyazaki, Junichi Iwamoto, Takeshi Hirayama, Yoshifumi Saito, Hajime Takikawa, Michio Imawari and Yasushi Matsuzaki

    Version of Record online : 5 APR 2013, DOI: 10.1002/hep.26018

  6. Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis

    Hepatology Research

    Volume 45, Issue 8, August 2015, Pages: 846–855, Minoru Nakamura, Hisayoshi Kondo, Atsushi Tanaka, Atsumasa Komori, Masahiro Ito, Kazuhide Yamamoto, Hiromasa Ohira, Mikio Zeniya, Etsuko Hashimoto, Masao Honda, Shuichi Kaneko, Yoshiyuki Ueno, Kentaro Kikuchi, Shinji Shimoda, Kenichi Harada, Kuniaki Arai, Yasuhiro Miyake, Masanori Abe, Makiko Taniai, Toshiji Saibara, Shotaro Sakisaka, Hajime Takikawa, Morikazu Onji, Hirohito Tsubouchi, Yasuni Nakanuma and Hiromi Ishibashi

    Version of Record online : 11 DEC 2014, DOI: 10.1111/hepr.12423

  7. You have free access to this content
    Ursodeoxycholic acid — adverse effects and drug interactions

    Alimentary Pharmacology & Therapeutics

    Volume 18, Issue 10, November 2003, Pages: 963–972, W. Hempfling, K. Dilger and U. Beuers

    Version of Record online : 14 NOV 2003, DOI: 10.1046/j.1365-2036.2003.01792.x

  8. You have free access to this content
    Poster Session 1: Cholestasis and Autoimmune Liver Disease

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 339A–369A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27496

  9. Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor

    Allergy

    Volume 67, Issue 12, December 2012, Pages: 1501–1510, M. A. M. Willart, M. van Nimwegen, A. Grefhorst, H. Hammad, L. Moons, H. C. Hoogsteden, B. N. Lambrecht and A. KleinJan

    Version of Record online : 25 SEP 2012, DOI: 10.1111/all.12019

  10. You have free access to this content
    Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat

    Hepatology

    Volume 52, Issue 2, August 2010, Pages: 667–677, Carlos M. Rodríguez-Ortigosa, Jesús M. Banales, Israel Olivas, Iker Uriarte, José J.G. Marín, Fernando J. Corrales, Juan F. Medina and Jesús Prieto

    Version of Record online : 8 APR 2010, DOI: 10.1002/hep.23709

  11. You have free access to this content
    Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling

    British Journal of Pharmacology

    Volume 171, Issue 22, November 2014, Pages: 5113–5126, Anita Pathil, Jan Mueller, Johannes M Ludwig, Jiliang Wang, Arne Warth, Walee Chamulitrat and Wolfgang Stremmel

    Version of Record online : 5 SEP 2014, DOI: 10.1111/bph.12837

  12. You have free access to this content
    UDCA slows down intestinal cell proliferation by inducing high and sustained ERK phosphorylation

    International Journal of Cancer

    Volume 130, Issue 12, 15 June 2012, Pages: 2771–2782, S. Krishna-Subramanian, M.L. Hanski, C. Loddenkemper, B. Choudhary, G. Pagès, M. Zeitz and C. Hanski

    Version of Record online : 30 AUG 2011, DOI: 10.1002/ijc.26336

  13. Chronologic changes of explanted liver volume and the use of ursodeoxycholic acid in patients with end-stage primary biliary cirrhosis

    Hepatology Research

    Volume 44, Issue 9, September 2014, Pages: 993–999, Tomohiro Tanaka, Noriyo Yamashiki, Yasuhiko Sugawara, Sumihito Tamura, Minoru Nakamura, Junichi Kaneko, Taku Aoki, Yoshihiro Sakamoto, Kiyoshi Hasegawa and Norihiro Kokudo

    Version of Record online : 9 JAN 2014, DOI: 10.1111/hepr.12283

  14. Biochemical response to ursodeoxycholic acid predicts long-term outcome in Japanese patients with primary biliary cirrhosis

    Hepatology Research

    Volume 41, Issue 4, April 2011, Pages: 310–317, Nobuaki Azemoto, Teru Kumagi, Masanori Abe, Ichiro Konishi, Bunzo Matsuura, Yoichi Hiasa and Morikazu Onji

    Version of Record online : 22 MAR 2011, DOI: 10.1111/j.1872-034X.2011.00782.x

  15. You have full text access to this OnlineOpen article
    Ursodeoxycholic acid treatment in a rat model of cancer cachexia

    Journal of Cachexia, Sarcopenia and Muscle

    Volume 3, Issue 1, March 2012, Pages: 31–36, Anika Tschirner, Stephan von Haehling, Sandra Palus, Wolfram Doehner, Stefan D. Anker and Jochen Springer

    Version of Record online : 21 OCT 2011, DOI: 10.1007/s13539-011-0044-4

  16. Pharmacological interventions for primary biliary cholangitis

    Intervention Review

    The Cochrane Library

    Francesca Saffioti, Kurinchi Selvan Gurusamy, Leonardo Henry Eusebi, Emmanuel Tsochatzis, Brian R Davidson and Douglas Thorburn

    Published Online : 28 MAR 2017, DOI: 10.1002/14651858.CD011648.pub2

  17. Abstracts of papers submitted to the american association for the study of liver diseases

    Hepatology

    Volume 18, Issue S7, October 1993, Pages: 57A–346A,

    Version of Record online : 12 DEC 2005, DOI: 10.1002/hep.1840180703

  18. You have free access to this content
    Serum vitamin D level is associated with disease severity and response to ursodeoxycholic acid in primary biliary cirrhosis

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 2, July 2015, Pages: 221–230, G.-Y. Guo, Y.-Q. Shi, L. Wang, X. Ren, Z.-Y. Han, C.-C. Guo, L.-N. Cui, J.-B. Wang, J. Zhu, N. Wang, J. Zhang, Y. Cai, Y. Han, X.-M. Zhou and D.-M. Fan

    Version of Record online : 18 MAY 2015, DOI: 10.1111/apt.13244

  19. You have free access to this content
    Systematic review: management options for primary sclerosing cholangitis and its variant forms – IgG4-associated cholangitis and overlap with autoimmune hepatitis

    Alimentary Pharmacology & Therapeutics

    Volume 33, Issue 12, June 2011, Pages: 1273–1291, E. L. Culver and R. W. Chapman

    Version of Record online : 18 APR 2011, DOI: 10.1111/j.1365-2036.2011.04658.x

  20. You have free access to this content
    Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy

    British Journal of Clinical Pharmacology

    Volume 79, Issue 2, February 2015, Pages: 316–329, Maria C. Estiú, Maria J. Monte, Laura Rivas, Maria Moirón, Laura Gomez-Rodriguez, Tomas Rodriguez-Bravo, Jose J.G. Marin and Rocio I.R. Macias

    Version of Record online : 20 JAN 2015, DOI: 10.1111/bcp.12480